| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.17B | -17.0% |
| Cost of Revenue | $706.1M | -25.8% |
| Gross Profit | $461.5M | +1.5% |
| R&D Expense | $28.4M | +1.1% |
| SG&A Expense | $171.2M | +2.7% |
| Operating Income | $418.7M | +13.5% |
| Interest Expense | $78.3M | -19.9% |
| Pre-tax Income | -$142.1M | +73.5% |
| Income Tax | $8.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78.1M | +14.9% |
| Inventory | $186.0M | -18.0% |
| Current Assets | $454.2M | -7.9% |
| Total Assets | $1.65B | -18.4% |
| Current Liabilities | $341.3M | +29.2% |
| Long-term Debt | $1.16B | -13.3% |
| Total Liabilities | $1.62B | -11.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $331.2M | +157.5% |
| Investing Cash Flow | -$57.5M | +27.7% |
| Financing Cash Flow | -$252.2M | -259.3% |
| +107.8% |
| Net Income | -$167.1M | +61.2% |
| EPS (Basic) | -$4.61 | +61.1% |
| EPS (Diluted) | -$4.61 | +61.1% |
| Stockholders' Equity |
| $29.7M |
| -84.8% |